Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA Sequencing of 16D prostate xenograft tumors with genetic knockout of OGDHL

ABSTRACT: The goal of this study was to perform transcriptomics of xenograft tumors generated from prostate cancer cells with genetic knockout of OGDHL vs a control knockout

ORGANISM(S): Homo sapiens

PROVIDER: GSE297510 | GEO | 2025/06/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA Sequencing of 16D prostate xenograft tumors with genetic knockout of OGDHL

Project description:RNA Sequencing of 16D prostate xenograft tumors with genetic knockout of OGDHL

| PRJNA1265110 | ENA

RNA Sequencing of 16D Prostate Cancer Cell Lines with genetic knockout of OGDHL

Project description:The goal of this study was to perform transcriptomics of prostate cancer cells with genetic knockout of OGDHL treated with the Androgen Receptor Pathway Inhibitor Enzalutamide (Enza) or Vehicle (DMSO)

2025-06-06 | GSE298123 | GEO

RNA Sequencing of 16D Prostate Cancer Cell Lines with genetic knockout of OGDHL

Project description:RNA Sequencing of 16D Prostate Cancer Cell Lines with genetic knockout of OGDHL

| PRJNA1268387 | ENA

The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors

Project description:Despite significant advancements in prostate cancer detection and treatment, the molecular mechanisms driving its progression remain elusive. This study aimed to explore the role of the receptor OR51E2, which is frequently upregulated in prostate cancer, in the disease's progression. Using CRISPR-Cas9 technology, we generated monoclonal OR51E2 knockout cells to investigate the receptor's physiological effects. We assessed the tumorigenic potential of these cells both in vitro and in vivo, and conducted transcriptomic and proteomic analyses on xenograft tumors derived from the knockout cells. Additionally, we examined how varying levels of OR51E2 expression in patients from a TCGA cohort impacted disease outcomes. The OR51E2-knockout cells displayed increased proliferation, migration, adhesion, anchorage-independent colony formation, and tumor growth, leading to a more aggressive cancer phenotype. Omics analyses identified several pathways associated with significant molecular changes, particularly an aberration in the STAT3 pathway linked to IL-6 signaling, underscoring a connection to inflammatory pathways. Analysis of the TCGA cohort further revealed that prostate cancer patients with lower OR51E2 expression had worse prognoses and higher average Gleason grades compared to those with higher expression levels. This analysis also supported a role for OR51E2 in modulating the STAT3 pathway within the cohort. Overall, our findings suggest that OR51E2 plays a critical role in regulating prostate cancer progression by influencing cancer cell physiology and aggressiveness. Reduced OR51E2 expression may lead to poorer patient outcomes, potentially through disruptions in the STAT3 pathway that alter cellular responses to inflammatory signaling.

2025-03-24 | GSE276348 | GEO

Gene expression profile in prostate cancer xenograft tumors after FGFRL1 knockdown

Project description:FGFRs regulate PCa development and progression, but the role of the recently found FGFR-like 1 (FGFRL1) remains unclear. The data consists of gene expression profiles of mouse subcutanous xenograft tumors generated of human PC3M prostate cancer cells with stable knockdown of FGFRL1 gene and of the control xenografts.

2022-01-11 | GSE174361 | GEO

RNA sequencing of wildtype, PTEN single knockout (SKO), and PTEN;Rb1 double knockout (DKO) mouse prostate organoids

Project description:The goal of this study was to perform transcriptomics on wildtype, PTEN single knockout (SKO) and PTEN;Rb1 double knockout (DKO) mouse prostate organoids. We isolated basal cells from PTEN floxed and PTEN;Rb1 floxed mouse prostates and infected with either RFP control or Cre recombinase to establish wildtype, SKO, and DKO mouse prostate organoids.

2023-09-01 | GSE221020 | GEO

Gene expression profile in prostate cancer xenograft tumors after FGFRL1 knockdown

Project description:Gene expression profile in prostate cancer xenograft tumors after FGFRL1 knockdown

| PRJNA729514 | ENA

CXCR4-LASP1-G9a-SNAIL Axis Drives NEPC Transdifferentiation via Induction of EMT and Downregulation of REST [16D CRPC xenograft]

Project description:Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer that can develop from prostate cancer following aggressive hormonal therapy. Unfortunately, there are few treatment options available and new therapeutic targets and more effective treatments are urgently needed to improve management of the disease. There is now little doubt that the majority of NEPC is derived from prostatic adenocarcinoma cells via “NE transdifferentiation” that is driven at least in part by AR-axis interference and lineage plasticity. We have developed a first-in-field patient-derived xenograft model of a prostatic adenocarcinoma (LTL331) that undergoes a complete transdifferentiation to NEPC (LTL331R) upon host castration. Using this unique, high-fidelity, patient-derived prostate cancer xenograft models and powerful genomic and transcriptomic analyses, we have obtained evidence that therapy induced development of NEPC may result from epigenetic alterations which drives lineage plasticity of dormancy-capable cancer cells and functional evaluation of key regulators. These findings may lead to more suitable targets and better therapeutic strategies for prevention and treatment of NEPC.

2025-05-11 | GSE296568 | GEO

Expression in prospectively purified human prostate orthotopic xenograft tumor cells with varying S/TFE

Project description:This SuperSeries is composed of the following subset Series: GSE25690: Global analysis of mRNA expression in prospectively purified human prostate orthotopic xenograft tumor cells with varying S/TFE. GSE25691: Global analysis of miRNA expression in prospectively purified human prostate orthotopic xenograft tumor cells with varying S/TFE. Refer to individual Series

2010-12-06 | E-GEOD-25692 | biostudies-arrayexpress

Expression data from uncastrasion and castration tumor from LNCAP Orhotopic xenograft models of prostate cancer

Project description:To identify molecular singnal alterations between androgen dependent prostate cancer and castration resistant prostate cancer, we performed interspecies comparative microarray analyses using RNAs prepared from uncastrasion and castration tumor from LNCAP Orhotopic xenograft models of prostate cancer. microarray data from uncastrasion and castration tumor revealed that the gene expression profile is most significantly altered in between androgen dependent prostate cancer and castration resistant prostate cancer. Comparative analyses of LNCAP Orhotopic xenograft models of prostate cancer showed that genes involved in androgen dependent and androgen independent tumor were significantly altered. We prepared RNA samples from 4 samples uncastrasion and 4 samples castration tumors from LNCAP Orhotopic xenograft models of prostate cancer . High-quality RNA samples were subjected to microarray analysis using the Affymetrix Human Gene 2.0 ST platform, and only those results that passed examinations for quality assurance and quality control of the Human Gene 2.0 ST arrays were retrieved. In total, we obtained gene expression profiles from the following samples: 4 samples uncastrasion and 4 samples castration tumors

2013-04-20 | E-GEOD-46218 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data